News

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology\'s In the Lab eNewsletter-04-03-2019
Volume14
Issue 4

New Protein Characterization Technique Unveiled at Pittcon 2019

Microsaic Systems showcased its new MiD ProteinID point-of-need mass spectrometer at Pittcon in Philadelphia, PA, from March 18–21, 2019.

Microsaic’s MiD ProteinID point-of-need mass spectrometer allows users to verify target proteins, metabolites, by-products and feed-stocks throughout the whole bioprocessing value chain and offers laboratory-level performance on an industrial scale.

By providing deterministic characterization for proteins and small molecules at the point-of-need, the mass spectrometer helps to ensure critical process parameters and critical quality attributes are attained timely, and simultaneously, which is vital for biologics compliance, according to the company.

“Our MiD ProteinID system is a process analytical game changer. Bioprocessing operators can now monitor feedstocks, metabolites, and target proteins in just one measurement, accelerating time-to-market for new biologics and assisting in process and product compliance,” said Glenn Tracey, CEO, Microsaic Systems, in a company press release. “Mass spectrometry can now offer superlative performance to high-value manufacturing industries at the point-of-need, providing much greater insights over ubiquitous optical sensors, such as [ultraviolet], Raman, and [near infrared].”

The mass spectrometer was showcased at booth 4131 at Pittcon 2019 in Philadelphia, PA, which took place from March 17–21, 2019.

Source: Microsaic Systems

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content